One PrEP Regimen Linked to Higher Risk of Hypertension, Statin Use Over Another
(MedPage Today) -- Use of tenofovir alafenamide fumarate (TAF) for HIV pre-exposure prophylaxis (PrEP) was associated with an increased risk of hypertension and the initiation of statin use within 2 years compared with the use of tenofovir disoproxil...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Cardiology | Cardiovascular | Cholesterol | Heart | Hypertension | Statin Therapy | Viread